A new era for treating high-risk neuroblastoma – research advances to look out for in 2024 24 Apr 2024 It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to further advance this research. We look at some of the latest advances and how they could change the outlook for children with neuroblastoma. Find out more Show/Hide
‘The role of advocacy is extremely important’ – improving treatment for the childhood cancer neuroblastoma 28 Sep 2023 Much of our cutting-edge work is only possible because of the help we receive from our supporters, including our wonderful family charity partners. Dr Sally George, who leads our Developmental Oncology group at the ICR, explains why these partnerships are so important. Find out more Show/Hide
“Research is what’s going to save these children” – Siobhan’s story 21 Sep 2023 Siobhan Mather was two years old when she became lethargic and didn’t want to eat. Tests revealed she had a tumour above her adrenal gland - it was neuroblastoma. With treatment, Siobhan went into remission and her family and friends raised money to fund a trial abroad. Sadly, the cancer returned, and Siobhan was unable to travel. She passed away in June 2019 when she was four years old. Her parents, Sarah and Antony Mather, explain how they’re using the funds raised to support our research as one of our valued family charity partners. Find out more Show/Hide
Rising to the challenge: meet one of our researchers applying expertise in breast cancer research to make gains in childhood cancer 16 Dec 2021